The global interventional cardiology devices market size was estimated at USD 11.3 billion in 2025 and is projected to reach USD 19.8 billion by 2033, growing at a CAGR of 7.3% from 2026 to 2033. The interventional cardiology devices industry is driven by rising cardiovascular disease (CVD) prevalence, fueled by obesity, hypertension, diabetes, aging populations, sedentary lifestyles, and unhealthy diets. The growing burden of heart-related disorders has increased the demand for advanced diagnostic and therapeutic procedures that enable effective treatment while minimizing patient recovery time. As healthcare systems focus on improving cardiovascular outcomes, the adoption of interventional cardiology devices continues to expand across hospitals and specialized cardiac care centers worldwide.

The market is witnessing increasing utilization of minimally invasive cardiovascular procedures due to their advantages over traditional surgical approaches. These procedures help reduce hospital stays, lower procedural risks, and improve patient recovery rates. Technological advancements in device design, imaging systems, and catheter-based interventions are also supporting market growth by enhancing procedural accuracy and treatment effectiveness. Growing awareness regarding early diagnosis and timely treatment of cardiovascular diseases further contributes to the expansion of the interventional cardiology devices industry.

Download a free sample copy of the Interventional Cardiology Devices market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

• North America dominated the global interventional cardiology devices market with the largest revenue share of 46.1% in 2025. The region's leadership is supported by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, strong adoption of innovative medical technologies, and significant healthcare spending. The presence of major medical device manufacturers and favorable reimbursement frameworks has further contributed to market growth across North America.
• The interventional cardiology devices industry in the U.S. accounted for the largest market revenue share in North America in 2025. The country's market growth is supported by increasing cardiovascular disease incidence, widespread access to advanced cardiac treatment facilities, and ongoing investments in healthcare innovation. The growing adoption of minimally invasive cardiac procedures and strong availability of specialized healthcare professionals continue to support market expansion.
• By product, the coronary stents segment led the market with the largest revenue share of 48.3% in 2025. Coronary stents remain a critical component in the treatment of blocked or narrowed coronary arteries, helping restore blood flow and reduce the risk of serious cardiac events. Their extensive use in percutaneous coronary intervention procedures and continuous advancements in stent technology have contributed significantly to the segment's leading position in the market.
• By procedures, the coronary artery disease (CAD) segment led the market with the largest revenue share of 52.2% in 2025. The high prevalence of coronary artery disease worldwide has increased the demand for effective interventional treatment options. Growing awareness regarding cardiovascular health, increasing diagnostic rates, and advancements in catheter-based therapies have supported the dominance of this segment within the interventional cardiology devices market.
• In terms of the end use segment, the hospital segment accounted for the largest market revenue share in 2025. Hospitals serve as the primary centers for cardiovascular diagnosis, intervention, and post-procedure care. Their access to advanced medical equipment, specialized cardiac units, and skilled healthcare professionals enables the efficient delivery of interventional cardiology procedures. The increasing number of cardiac interventions performed in hospital settings continues to support the segment's leading market position.

Looking for more specific insights? Customize this report to suite your business needs

Key Interventional Cardiology Devices Companies:

• Abbott
• Medtronic
• Boston Scientific Corporation
• Cardinal Health
• Koninklijke Philips N.V.
• Terumo Corporation
• Alvimedica
• Teleflex Incorporated
• B. Braun SE
• Biosensors International Group, Ltd.
• Meril Life Sciences Pvt. Ltd.
• BIOTRONIK
• ACIST Medical Systems
• ASAHI INTECC CO., LTD.
• Cook
• Medinol
• Merit Medical Systems
• Numed, Inc.
• OpSens (Acquired by Haemonetics)
• Zeon Medical (KANEKA CORPORATION)

Recent Developments

• In February 2026, ACIST Medical Systems, part of the Bracco Group, introduced the ACIST Pro Diagnostic System in select European markets. This advanced variable-rate contrast management system enhances precision, safety, and efficiency for image-guided cardiovascular procedures.
• In September 2025, Cook and Siemens Healthineers partnered to develop an integrated Interventional MRI (iMRI) suite, providing MRI-guided, radiation-free imaging for structural heart procedures. The system, still under development, is designed to enhance precision in minimally invasive cardiac interventions while eliminating ionizing radiation for patients and clinicians.
• In May 2025, Terumo Interventional Systems announced the commercial availability of its ROADSAVER carotid stent system. The device is designed to provide reliable support and safety during carotid artery interventions, enhancing procedural outcomes for patients at risk of stroke. 

Explore Grand View Horizon to see global and regional level statistics related to the Interventional Cardiology Devices Market

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering